| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maxton E Thoman, Susan C McKarn. Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery. Metabolites. vol 10. issue 9. 2021-08-30. PMID:32961928. |
pathogenic autoantibiotics that target the water channel aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) contribute to nmosd pathology. |
2021-08-30 |
2023-08-13 |
Not clear |
| Peng Bai, Meini Zhang, Jun Yuan, Runxiu Zhu, Na L. A comparison of the effects of rituximab versus other immunotherapies for MOG-IgG-associated central nervous system demyelination: A meta-analysis. Multiple sclerosis and related disorders. vol 53. 2021-08-24. PMID:34091176. |
myelin oligodendrocyte glycoprotein (mog) antibody disease (mog-ad) is now recognised as a nosological entity with specific clinical and paraclinical features to aid early diagnosis. |
2021-08-24 |
2023-08-13 |
Not clear |
| Yun-Feng Wang, Xue-Wu Liu, Jian-Ming Lin, Ji-Ye Liang, Xiu-He Zhao, Sheng-Jun Wan. The Clinical Features of FLAIR-Hyperintense Lesions in Anti-MOG Antibody Associated Cerebral Cortical Encephalitis with Seizures: Case Reports and Literature Review. Frontiers in immunology. vol 12. 2021-08-23. PMID:34177880. |
the presence of fluid attenuated inversion recovery (flair)-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein (mog) antibody-associated cerebral cortical encephalitis with seizures (flamces) was recently reported. |
2021-08-23 |
2023-08-13 |
Not clear |
| Krenar Veselaj, Nicole Kamber, Myriam Briner, Christoph Friedli, Lara Diem, Kirsten Guse, Andrei Miclea, Roland Wiest, Franca Wagner, Hilary Grabe, Mathias Abegg, Michael P Horn, Sandra Bigi, Andrew Chan, Robert Hoepner, Anke Salme. Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. CNS neuroscience & therapeutics. vol 27. issue 4. 2021-08-18. PMID:33047894. |
myelin oligodendrocyte glycoprotein antibodies (mog-igg) have been proposed to define "mog encephalomyelitis" (mog-em), with published diagnostic and "red flag" criteria. |
2021-08-18 |
2023-08-13 |
Not clear |
| Solène Dauby, Dominique Dive, Laurence Lutteri, Cécile Andris, Isabelle Hansen, Pierre Maquet, Emilie Lommer. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort. Acta neurologica Belgica. 2021-08-17. PMID:34097296. |
to emphasize physio-pathological, clinical and prognosis differences between conditions causing serious and sometimes very similar clinical manifestations: anti-aquaporin-4 (aqp4) and anti-myelin oligodendrocyte glycoprotein (mog) antibodies related diseases, and seronegative nmosd (neuromyelitis optica spectrum disorders). |
2021-08-17 |
2023-08-13 |
Not clear |
| Romain Deschamps, Julie Pique, Xavier Ayrignac, Nicolas Collongues, Bertrand Audoin, Hélène Zéphir, Jonathan Ciron, Mikael Cohen, Jennifer Aboab, Guillaume Mathey, Nathalie Derache, David Laplaud, Eric Thouvenot, Bertrand Bourre, Aurélie Ruet, Françoise Durand-Dubief, Valérie Touitou, Catherine Vignal-Clermont, Caroline Papeix, Olivier Gout, Romain Marignier, Elisabeth Maillar. The long-term outcome of MOGAD: An observational national cohort study of 61 patients. European journal of neurology. vol 28. issue 5. 2021-08-12. PMID:33528851. |
the prognosis in myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is a matter of debate. |
2021-08-12 |
2023-08-13 |
Not clear |
| Melanie Truong-Le, Bart Chwalis. Antibody Testing in Atypical Optic Neuritis. Seminars in ophthalmology. vol 35. issue 5-6. 2021-08-11. PMID:33150802. |
the last two decades have seen increasing recognition of atypical optic neuritis syndromes, driven in large part by characterization of demyelinating diseases associated with antibodies to aquaporin 4 (aqp4) and myelin oligodendrocyte glycoprotein (mog). |
2021-08-11 |
2023-08-13 |
Not clear |
| Kosuke Shimizu, Kazuki Agata, Shohei Takasugi, Shungo Goto, Yudai Narita, Tomohiro Asai, Yasuhiro Magata, Naoto Ok. New strategy for MS treatment with autoantigen-modified liposomes and their therapeutic effect. Journal of controlled release : official journal of the Controlled Release Society. vol 335. 2021-08-11. PMID:34033858. |
in these experiments, experimental autoimmune encephalomyelitis (eae) induced by autoantigenic myelin oligodendrocyte glycoprotein (mog) peptide was used as a model of primary progressive ms, and mog-modified liposomes encapsulating doxorubicin (mog-lipdox) were used as a therapeutic drug. |
2021-08-11 |
2023-08-13 |
mouse |
| Z-Z Ge, Y-B Wu, Z-Y Xue, K Zhang, R-X Zhan. The therapeutic effects of the peptidyl-prolyl cis/trans isomerase Pin1 inhibitor juglone on animal-model experimental autoimmune encephalomyelitis. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. vol 72. issue 2. 2021-08-11. PMID:34374656. |
eae was induced in c57bl/6 mice with myelin oligodendrocyte glycoprotein (mog) |
2021-08-11 |
2023-08-13 |
mouse |
| A García Ortega, F J Montañez Campos, S Muñoz, B Sanchez-Dalma. Autoimmune and demyelinating optic neuritis. Archivos de la Sociedad Espanola de Oftalmologia. vol 95. issue 8. 2021-08-05. PMID:32622510. |
finally, the latest insights into myelin oligodendrocyte glycoprotein (mog) disorders and chronic-recurring optic neuropathies (crion) are highlited. |
2021-08-05 |
2023-08-13 |
Not clear |
| Shengde Li, Haitao Ren, Yan Xu, Tao Xu, Yao Zhang, Hexiang Yin, Weihua Zhang, Jiuwei Li, Xiaotun Ren, Fang Fang, Wenhan Li, Yicheng Zhu, Bin Peng, Jing Wang, Yong Zhong, Liying Cu. Long-term efficacy of mycophenolate mofetil in myelin oligodendrocyte glycoprotein antibody-associated disorders: A prospective study. Neurology(R) neuroimmunology & neuroinflammation. vol 7. issue 3. 2021-08-02. PMID:32170045. |
to investigate whether the use of mycophenolate mofetil (mmf) could reduce the relapse risk in patients with myelin oligodendrocyte glycoprotein (mog)-immunoglobulin g (igg)-associated disorders (mogads). |
2021-08-02 |
2023-08-13 |
Not clear |
| Zheng Xu, Chun-Chieh Lin, Sophey Ho, George Vlad, Nicole Suciu-Foc. Suppression of Experimental Autoimmune Encephalomyelitis by ILT3.Fc. Journal of immunology (Baltimore, Md. : 1950). vol 206. issue 3. 2021-08-02. PMID:33361206. |
the murine model of ms is the experimental autoimmune encephalopathy (eae) induced by immunization of mice with myelin oligodendrocyte glycoprotein (mog) |
2021-08-02 |
2023-08-13 |
mouse |
| Bardia Nourbakhsh, Christian Cordano, Carlo Asteggiano, Klemens Ruprecht, Carolin Otto, Alice Rutatangwa, Allysa Lui, Janace Hart, Eoin P Flanagan, Judith A James, Emmanuelle Wauban. Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination. Annals of neurology. vol 89. issue 6. 2021-08-02. PMID:33704815. |
when re-evaluating 25 ebv-seronegative children out of 189 pediatric patients with a diagnosis of clinically isolated syndrome/ms, we found anti-myelin oligodendrocyte glycoprotein (mog) antibody in 11 of 25 (44%) ebv-seronegative but only 9 of 164 (5.5%, p < 0.001) ebv-seropositive patients. |
2021-08-02 |
2023-08-13 |
Not clear |
| Ran Tao, Chuan Qin, Man Chen, Hai-Han Yu, Long-Jun Wu, Bi-Tao Bu, Dai-Shi Tia. Unilateral cerebral cortical encephalitis with epilepsy: a possible special phenotype of MOG antibody-associated disorders. The International journal of neuroscience. vol 130. issue 11. 2021-07-29. PMID:31971044. |
myelin oligodendrocyte glycoprotein (mog) antibody-related encephalomyelitis is an increasingly recognized entity with heterogeneity in phenotype. |
2021-07-29 |
2023-08-13 |
Not clear |
| L Mohammadnejad, A Zare Mirakabadi, Sh Oryan, Sh Jelodar Dezfoul. Anti-inflammatory Activity of Caspian Cobra (Naja naja oxiana) Snake Venom on the Serum Level of Interleukin-27 and Histopathological Changes in Myelin Oligodendrocyte Glycoprotein-experimental Autoimmune Encephalomyelitisinduced Mice. Archives of Razi Institute. vol 75. issue 4. 2021-07-29. PMID:33403844. |
groups 2 and 3 received flank injection with the emulsion of myelin oligodendrocyte glycoprotein (mog 35-55), as well as complete freund adjuvant, followed by the administration of pertussis toxin. |
2021-07-29 |
2023-08-13 |
mouse |
| Dana Rebecca Siegel, Thanh-Ha Luu, Malgorzata E Skaznik-Wikie. Primary Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-associated Optic Neuritis Presenting after a Frozen Embryo Transfer. Journal of human reproductive sciences. vol 14. issue 2. 2021-07-29. PMID:34316239. |
myelin oligodendrocyte glycoprotein (mog)-immunoglobulin g-associated optic neuritis (on) is a newly recognized antibody-mediated demyelinating disease of the central nervous system, resulting in acute visual loss and pain with eye movement. |
2021-07-29 |
2023-08-13 |
Not clear |
| Jonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, Bertrand Bourre, David Brassat, Mikael Cohen, Nicolas Collongues, Romain Deschamps, Françoise Durand-Dubief, David Laplaud, Elisabeth Maillart, Caroline Papeix, Hélène Zephir, Matthieu Bereau, Bruno Brochet, Clarisse Carra-Dallière, Nathalie Derache, Clarisse Gagou-Scherer, Carole Henry, Philippe Kerschen, Guillaume Mathey, Nicolas Maubeuge, Aude Maurousset, Alexis Montcuquet, Thibault Moreau, Christophe Prat, Frédéric Taithe, Eric Thouvenot, Ayman Tourbah, Fabien Rollot, Sandra Vukusic, Romain Marignie. Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study. Multiple sclerosis (Houndmills, Basingstoke, England). vol 26. issue 8. 2021-07-28. PMID:31148523. |
we aim to (1) determine the frequency and distinctive features of short myelitis (sm) and longitudinally extensive transverse myelitis (letm) in a cohort of adults with myelin oligodendrocyte glycoprotein (mog)-antibody (ab)-associated myelitis and (2) determine baseline prognostic factors among mog-ab-positive patients whose disease started with myelitis. |
2021-07-28 |
2023-08-13 |
Not clear |
| Sven Jarius, Hannah Pellkofer, Nadja Siebert, Mirjam Korporal-Kuhnke, Martin W Hümmert, Marius Ringelstein, Paulus S Rommer, Ilya Ayzenberg, Klemens Ruprecht, Luisa Klotz, Nasrin Asgari, Tobias Zrzavy, Romana Höftberger, Rafik Tobia, Mathias Buttmann, Kai Fechner, Kathrin Schanda, Martin Weber, Susanna Asseyer, Jürgen Haas, Christian Lechner, Ingo Kleiter, Orhan Aktas, Corinna Trebst, Kevin Rostasy, Markus Reindl, Tania Kümpfel, Friedemann Paul, Brigitte Wildeman. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. Journal of neuroinflammation. vol 17. issue 1. 2021-07-21. PMID:32883348. |
cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (mog) antibodies. |
2021-07-21 |
2023-08-13 |
human |
| Sven Jarius, Christian Lechner, Eva M Wendel, Matthias Baumann, Markus Breu, Mareike Schimmel, Michael Karenfort, Adela Della Marina, Andreas Merkenschlager, Charlotte Thiels, Astrid Blaschek, Michela Salandin, Steffen Leiz, Frank Leypoldt, Alexander Pschibul, Annette Hackenberg, Andreas Hahn, Steffen Syrbe, Jurgis Strautmanis, Martin Häusler, Peter Krieg, Astrid Eisenkölbl, Johannes Stoffels, Matthias Eckenweiler, Ilya Ayzenberg, Jürgen Haas, Romana Höftberger, Ingo Kleiter, Mirjam Korporal-Kuhnke, Marius Ringelstein, Klemens Ruprecht, Nadja Siebert, Kathrin Schanda, Orhan Aktas, Friedemann Paul, Markus Reindl, Brigitte Wildemann, Kevin Rostás. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients. Journal of neuroinflammation. vol 17. issue 1. 2021-07-21. PMID:32883358. |
cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (mog) antibodies. |
2021-07-21 |
2023-08-13 |
human |
| Sa-Ying Zhu, Jing Peng, Lei-Lei Mao, Xiao-Lu Deng, Ci-Liu Zhang, Li-Fen Yang, Fei Yin, Fang H. [Recurrence factors for myelin oligodendrocyte glycoprotein antibody disease in children and the effect of recurrence prevention regimens]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. vol 23. issue 7. 2021-07-19. PMID:34266531. |
to study the clinical features and recurrence factors of myelin oligodendrocyte glycoprotein (mog) antibody disease in children and the effect of recurrence prevention regimens. |
2021-07-19 |
2023-08-13 |
Not clear |